- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Rat Models of Hormone Receptor-Positive Breast Cancer ; volume:29 ; number:1 ; day:24 ; month:6 ; year:2024 ; pages:1-26 ; date:12.2024
Journal of mammary gland biology and neoplasia ; 29, Heft 1 (24.6.2024), 1-26, 12.2024
- Creator
-
Nicotra, Raquel
Lutz, Catrin
Messal, Hendrik A.
Jonkers, Jos
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10911-024-09566-0
- URN
-
urn:nbn:de:101:1-2409170843521.314422739743
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
07.01.2025, 2:59 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nicotra, Raquel
- Lutz, Catrin
- Messal, Hendrik A.
- Jonkers, Jos
- SpringerLink (Online service)
Other Objects (12)
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer